Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| PROCEPT BioRobotics Corporation | PRCT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 52.48 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 52.48 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 24.83 - 54.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 52.48 | USD |
PROCEPT BioRobotics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.67B | 50.96M | - | 136.19M | -105.9M | -2.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
PROCEPT BioRobotics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRCT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 52.65 | 54.79 | 48.50 | 51.65 | 602,430 | -0.17 | -0.32% |
| 1 Month | 46.91 | 54.79 | 45.56 | 50.18 | 510,528 | 5.57 | 11.87% |
| 3 Months | 47.39 | 54.79 | 45.20 | 49.29 | 491,829 | 5.09 | 10.74% |
| 6 Months | 27.34 | 54.79 | 24.83 | 43.74 | 497,732 | 25.14 | 91.95% |
| 1 Year | 36.49 | 54.79 | 24.83 | 38.48 | 479,851 | 15.99 | 43.82% |
| 3 Years | 35.00 | 54.79 | 15.38 | 37.26 | 389,619 | 17.48 | 49.94% |
| 5 Years | 35.00 | 54.79 | 15.38 | 37.26 | 389,619 | 17.48 | 49.94% |
PROCEPT BioRobotics Description
| PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are primarily based in the United States. Its revenue is primarily generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. |
